LEVETIRACETAM DEXCEL 500

Maa: Israel

Kieli: englanti

Lähde: Ministry of Health

Aktiivinen ainesosa:

LEVETIRACETAM

Saatavilla:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC-koodi:

N03AX14

Lääkemuoto:

TABLETS

Koostumus:

LEVETIRACETAM 500 MG

Antoreitti:

PER OS

Prescription tyyppi:

Required

Valmistaja:

DEXCEL LTD, ISRAEL

Terapeuttinen ryhmä:

LEVETIRACETAM

Terapeuttinen alue:

LEVETIRACETAM

Käyttöaiheet:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Valtuutus päivämäärä:

2018-03-31